Finance

Lists
Why is 6541 down 2,55%?
Dive Deeper
6541:TPE
Tanvex Biopharma Inc
26,80ย NT$
-2,55%
(-0,70) 1D
17 ีถีธีต, 13:30:02 GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6541...
Open
27,50ย NT$
High
27,70ย NT$
Low
26,55ย NT$
Mkt. cap
7,11ย ีดีฌึ€ีค
Avg. vol.
457,10ย ีฐีฆึ€
Volume
264,12ย ีฐีฆึ€
52-wk high
65,50ย NT$
52-wk low
24,30ย NT$
EPS
-5,56ย NT$
Shares outstanding
242,67ย ีดีฌีถ
No. of employees
215
Open
27,50ย NT$
High
27,70ย NT$
Low
26,55ย NT$
Mkt. cap
7,11ย ีดีฌึ€ีค
Avg. vol.
457,10ย ีฐีฆึ€
Volume
264,12ย ีฐีฆึ€
52-wk high
65,50ย NT$
52-wk low
24,30ย NT$
EPS
-5,56ย NT$
Shares outstanding
242,67ย ีดีฌีถ
No. of employees
215
News stories
From web sources and news partners
BigGo Finance
BigGo Finance
·
35 ึ€ีธีบีฅ ีกีผีกีป
Netflix Shares Trade Below S&P 500 Multiple After 35% Slide as Analysts See Upside
Benzinga
Benzinga
·
39 ึ€ีธีบีฅ ีกีผีกีป
S&P 500 Down 1%; Disney Posts Upbeat Earnings
Barron's
Barron's
·
42 ึ€ีธีบีฅ ีกีผีกีป
Bear Market Watch: What the Charts Say About the S&P 500
Traders Union
Traders Union
·
35 ึ€ีธีบีฅ ีกีผีกีป
S&P 500 market cap falls $3 trillion over past week, Peter Tuchman notes
About Tanvex Biopharma Inc
CEO-
Employees215
Founded2011
Headquarters-
SectorHealth Care
Industry-
Websitetanvex.com
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
2025 ีฉ. ีคีฅีฏ
2026 ีฉ. ีดึ€ีฟ
2026 ีฉ. ีฐีถีฝ
2026 ีฉ. ีฝีฅีบ
Revenue
178,95ย ีดีฌีถ
132,83ย ีดีฌีถ
220,44ย ีดีฌีถ
158,84ย ีดีฌีถ
Cost of goods sold
422,66ย ีดีฌีถ
399,36ย ีดีฌีถ
446,37ย ีดีฌีถ
399,62ย ีดีฌีถ
Cost of revenue
422,66ย ีดีฌีถ
399,36ย ีดีฌีถ
446,37ย ีดีฌีถ
399,62ย ีดีฌีถ
Research and development expenses
13,26ย ีดีฌีถ
24,24ย ีดีฌีถ
19,86ย ีดีฌีถ
10,67ย ีดีฌีถ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
104,26ย ีดีฌีถ
108,51ย ีดีฌีถ
121,17ย ีดีฌีถ
108,24ย ีดีฌีถ
Operating expense
129,86ย ีดีฌีถ
133,70ย ีดีฌีถ
141,15ย ีดีฌีถ
118,94ย ีดีฌีถ
Total operating expenses
552,52ย ีดีฌีถ
533,06ย ีดีฌีถ
587,52ย ีดีฌีถ
518,56ย ีดีฌีถ
Operating income
-373,57ย ีดีฌีถ
-400,23ย ีดีฌีถ
-367,07ย ีดีฌีถ
-359,72ย ีดีฌีถ
Other non operating income
44,99ย ีดีฌีถ
188,00ย ีฐีฆึ€
418,00ย ีฐีฆึ€
-30,58ย ีดีฌีถ
EBT including unusual items
-420,53ย ีดีฌีถ
-388,70ย ีดีฌีถ
-382,53ย ีดีฌีถ
-405,98ย ีดีฌีถ
EBT excluding unusual items
-305,62ย ีดีฌีถ
-388,70ย ีดีฌีถ
-382,53ย ีดีฌีถ
-405,98ย ีดีฌีถ
Income tax expense
3,00ย ีฐีฆึ€
27,00ย ีฐีฆึ€
1,00ย ีฐีฆึ€
-5,84ย ีดีฌีถ
Effective tax rate
-
-0,01%
-
1,44%
Other operating expenses
-
-
-
25,00ย ีฐีฆึ€
Net income
-420,54ย ีดีฌีถ
-388,72ย ีดีฌีถ
-382,53ย ีดีฌีถ
-400,14ย ีดีฌีถ
Net profit margin
-235,00%
-292,65%
-173,53%
-251,92%
Earnings per share
-
-
-
-
Interest and investment income
11,66ย ีดีฌีถ
6,03ย ีดีฌีถ
5,01ย ีดีฌีถ
5,72ย ีดีฌีถ
Interest expense
-11,31ย ีดีฌีถ
-11,70ย ีดีฌีถ
-16,53ย ีดีฌีถ
-21,40ย ีดีฌีถ
Net interest expenses
354,00ย ีฐีฆึ€
-5,67ย ีดีฌีถ
-11,52ย ีดีฌีถ
-15,68ย ีดีฌีถ
Depreciation and amortization charges
-
-
-
-
EBITDA
-370,64ย ีดีฌีถ
-357,68ย ีดีฌีถ
-326,85ย ีดีฌีถ
-164,28ย ีดีฌีถ
Gain or loss from assets sale
62,12ย ีดีฌีถ
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google Apps